Published in Circ Res on July 06, 2012
Na(+) current expression in human atrial myofibroblasts: identity and functional roles. Front Physiol (2014) 0.82
Isolation of putative progenitor endothelial cells for angiogenesis. Science (1997) 30.27
Transient regenerative potential of the neonatal mouse heart. Science (2011) 9.02
Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation. Nature (2010) 6.65
The promise of induced pluripotent stem cells in research and therapy. Nature (2012) 5.05
Intramyocardial, autologous CD34+ cell therapy for refractory angina. Circ Res (2011) 3.72
Epigenetic signatures of stem-cell identity. Nat Rev Genet (2007) 3.56
Epigenetic characterization of the early embryo with a chromatin immunoprecipitation protocol applicable to small cell populations. Nat Genet (2006) 3.44
Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ Res (2012) 2.78
How cells change their phenotype. Nat Rev Mol Cell Biol (2002) 2.75
Aging and disease as modifiers of efficacy of cell therapy. Circ Res (2008) 2.51
Identification of a coronary vascular progenitor cell in the human heart. Proc Natl Acad Sci U S A (2009) 2.23
Oncostatin M is a major mediator of cardiomyocyte dedifferentiation and remodeling. Cell Stem Cell (2011) 1.72
Histone deacetylase activity is essential for the expression of HoxA9 and for endothelial commitment of progenitor cells. J Exp Med (2005) 1.56
Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial. Stem Cells (2009) 1.43
Epigenetic regulation of endothelial lineage committed genes in pro-angiogenic hematopoietic and endothelial progenitor cells. Circ Res (2011) 1.04
Concise review: Immune recognition of induced pluripotent stem cells. Stem Cells (2012) 0.98
Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell (2003) 18.09
Concern Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet (2011) 11.45
Chimerism of the transplanted heart. N Engl J Med (2002) 8.69
Human cardiac stem cells. Proc Natl Acad Sci U S A (2007) 7.76
Evidence for human lung stem cells. N Engl J Med (2011) 5.67
Stem cell niches in the adult mouse heart. Proc Natl Acad Sci U S A (2006) 4.58
Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci U S A (2005) 4.13
Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res (2004) 4.13
Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res (2005) 3.93
Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci U S A (2005) 3.93
Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci U S A (2005) 3.64
Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation (2010) 3.42
Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res (2004) 3.39
Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev (2005) 3.30
Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ Res (2008) 3.07
Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc Natl Acad Sci U S A (2007) 3.06
Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc Natl Acad Sci U S A (2003) 2.95
Nuclear targeting of Akt enhances kinase activity and survival of cardiomyocytes. Circ Res (2004) 2.91
Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation (2012) 2.83
Cardiomyogenesis in the adult human heart. Circ Res (2010) 2.79
Myocyte turnover in the aging human heart. Circ Res (2010) 2.77
Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology. Circ Res (2011) 2.76
Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene. Circ Res (2006) 2.71
Clonality of mouse and human cardiomyogenesis in vivo. Proc Natl Acad Sci U S A (2009) 2.60
Life and death of cardiac stem cells: a paradigm shift in cardiac biology. Circulation (2006) 2.56
Aging and disease as modifiers of efficacy of cell therapy. Circ Res (2008) 2.51
Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure. Circ Res (2003) 2.45
Pim-1 regulates cardiomyocyte survival downstream of Akt. Nat Med (2007) 2.39
Human cardiac stem cell differentiation is regulated by a mircrine mechanism. Circulation (2011) 2.38
Adolescent feline heart contains a population of small, proliferative ventricular myocytes with immature physiological properties. Circ Res (2007) 2.38
PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J Clin Invest (2005) 2.36
Akt promotes increased cardiomyocyte cycling and expansion of the cardiac progenitor cell population. Circ Res (2006) 2.34
Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Circ Res (2005) 2.32
Activation of cardiac progenitor cells reverses the failing heart senescent phenotype and prolongs lifespan. Circ Res (2008) 2.31
Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction. Circulation (2009) 2.30
Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci U S A (2003) 2.28
Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res (2003) 2.26
Identification of a coronary vascular progenitor cell in the human heart. Proc Natl Acad Sci U S A (2009) 2.23
Notch1 regulates the fate of cardiac progenitor cells. Proc Natl Acad Sci U S A (2008) 2.22
Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery. Circulation (2013) 2.19
Retracted Cardiomyogenesis in the aging and failing human heart. Circulation (2012) 2.16
Cardiac-specific IGF-1 expression attenuates dilated cardiomyopathy in tropomodulin-overexpressing transgenic mice. Circ Res (2002) 2.11
Dissecting the molecular relationship among various cardiogenic progenitor cells. Circ Res (2013) 2.06
Formation of large coronary arteries by cardiac progenitor cells. Proc Natl Acad Sci U S A (2008) 2.05
Functionally competent cardiac stem cells can be isolated from endomyocardial biopsies of patients with advanced cardiomyopathies. Circ Res (2011) 1.98
Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function. Circ Res (2006) 1.98
Myocardial induction of nucleostemin in response to postnatal growth and pathological challenge. Circ Res (2008) 1.97
Regenerating new heart with stem cells. J Clin Invest (2013) 1.83
Insulin-like growth factor-1 receptor identifies a pool of human cardiac stem cells with superior therapeutic potential for myocardial regeneration. Circ Res (2011) 1.77
Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes. Circulation (2013) 1.73
The young mouse heart is composed of myocytes heterogeneous in age and function. Circ Res (2007) 1.69
Cardiac regeneration. J Am Coll Cardiol (2006) 1.67
Bone marrow stem cells regenerate infarcted myocardium. Pediatr Transplant (2003) 1.66
Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation. EMBO J (2003) 1.66
Tracking chromatid segregation to identify human cardiac stem cells that regenerate extensively the infarcted myocardium. Circ Res (2012) 1.63
Nuclear targeting of Akt enhances ventricular function and myocyte contractility. Circ Res (2005) 1.62
Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function. Circulation (2009) 1.62
Age-associated defects in EphA2 signaling impair the migration of human cardiac progenitor cells. Circulation (2013) 1.61
Effects of age and heart failure on human cardiac stem cell function. Am J Pathol (2011) 1.57